Fulgent Genetics (FLGT) Restructuring Costs (2022 - 2026)
Fulgent Genetics' (FLGT) quarterly Restructuring Costs came in at $300000.0 in Q2 2026, down 88.46% quarter-over-quarter from $2.6 million in Q1 2026.
Analysis
Fulgent Genetics (FLGT) Restructuring Costs (2022 - 2026) Analysis & Trends
Fulgent Genetics has disclosed Restructuring Costs across 3 years of filings, most recently posting $300000.0 for Q2 2026.
- In Q2 2026, Restructuring Costs changed N/A year-over-year to $300000.0; the TTM figure through Jun 2026 stood at $6.5 million (up 8127.85% YoY), while the FY2025 annual figure was $1.5 million, changed N/A from the prior year.
- Restructuring Costs came in at $300000.0 for Q2 2026 at Fulgent Genetics, down from $2.6 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $2.9 million in Q2 2022 to a low of -$26000.0 in Q4 2022.
- Average Restructuring Costs over 3 years is $1.4 million, with a median of $1.5 million recorded in 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | 105,000.00 |
| Jun 30, 2022 | 2.90 Mn |